860
Participants
Start Date
January 15, 2025
Primary Completion Date
September 30, 2027
Study Completion Date
September 30, 2027
Isoniazid
Once daily weight-based dose
Rifampin
Once daily weight-based dose
Pyrazinamide
Once daily weight-based dose
Ethambutol
Once daily weight-based dose
Rifapentine
Once daily weight-based dose
Moxifloxacin
Once daily weight-based dose
NOT_YET_RECRUITING
Indian Council of Medical Research - National Institute for Research in Tuberculosis, Chennai
NOT_YET_RECRUITING
Dr. D.Y. Patil Medical College, Hospital and Research Center, Pune
NOT_YET_RECRUITING
Faculty of Medicine, Universitas Padjadjaran, Bandung
NOT_YET_RECRUITING
Instituto Nacional de Saúde (INS), Maputo
NOT_YET_RECRUITING
Africa Health Research Institute (AHRI), Durban
RECRUITING
MU-JHU Care Ltd, Kampala
RECRUITING
University of Zambia, School of Medicine, Lusaka
NOT_YET_RECRUITING
Arthur Davison Children's Hospital, Ndola
NOT_YET_RECRUITING
Harare Health and Research Consortium (HHRC), Harare
United States Agency for International Development (USAID)
FED
Johns Hopkins University
OTHER